ARTELO BIOSCIENCES, INC. Current Assets
ARTELO BIOSCIENCES, INC. (ARTL) had Current Assets of $4.37 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $4.37M.
- 2026-03-31: Assets, Current $10.42M.
- 2025-12-31: Assets, Current $695.00K.
- 2025-09-30: Assets, Current $1.83M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.37M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $10.42M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $695.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.83M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.23M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.38M 8-K · filed 2025-07-11 | |
| 2024-12-31 | $2.56M 8-K · filed 2026-03-17 | |
| 2024-09-30 | $4.99M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $6.17M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $8.19M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $10.98M 8-K · filed 2025-07-11 | |
| 2023-09-30 | $13.43M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $14.60M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $16.39M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $18.32M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $20.30M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $22.28M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $24.59M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $24.61M 10-K · filed 2023-03-31 | |
| 2021-11-30 | $25.36M 10-Q · filed 2022-01-12 | |
| 2021-08-31 | $10.32M 10-K · filed 2023-03-31 | |
| 2021-05-31 | $10.30M 10-Q · filed 2021-07-12 | |
| 2021-02-28 | $11.41M 10-Q · filed 2021-04-13 | |
| 2020-11-30 | $7.50M 10-Q · filed 2021-01-14 | |
| 2020-08-31 | $2.34M 10-KT · filed 2022-03-21 | $2.34M 10-K · filed 2020-11-04 |
| 2020-05-31 | $1.45M 10-Q · filed 2020-07-13 | |
| 2020-02-29 | $2.11M 10-Q · filed 2020-04-13 | |
| 2019-11-30 | $3.51M 10-Q · filed 2020-01-14 | |
| 2019-08-31 | $4.44M 10-K · filed 2020-11-04 | |
| 2019-05-31 | $1.15M 10-Q · filed 2019-07-15 | |
| 2019-02-28 | $483.87K 10-Q · filed 2019-04-15 | |
| 2018-11-30 | $164.88K 10-Q · filed 2019-01-14 | |
| 2018-08-31 | $396.44K 10-K/A · filed 2019-12-18 | |
| 2018-05-31 | $400.35K 10-Q · filed 2018-07-13 | |
| 2018-02-28 | $540.36K 10-Q/A · filed 2018-05-14 | |
| 2017-11-30 | $429.49K 10-Q/A · filed 2018-03-21 | |
| 2017-08-31 | $574.27K 10-K · filed 2018-11-29 | |
| 2017-05-31 | $227.84K 10-Q · filed 2017-07-21 | |
| 2017-02-28 | $13.46K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | $3.59K 10-Q · filed 2017-01-10 | |
| 2016-08-31 | $3.59K 10-K · filed 2017-11-29 | |
| 2016-05-31 | $3.59K 10-Q · filed 2016-07-05 | |
| 2016-02-29 | $3.59K 10-Q · filed 2016-04-01 | |
| 2015-11-30 | $3.97K 10-Q · filed 2016-01-14 | |
| 2015-08-31 | $17.03K 10-K · filed 2016-11-29 | |
| 2015-05-31 | $12.58K 10-Q · filed 2015-07-15 | |
| 2015-02-28 | $8.08K 10-Q · filed 2015-04-14 | |
| 2014-08-31 | $14.73K 10-K · filed 2015-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |